EBF1 is expressed in pericytes and contributes to pericyte cell commitment

Area of Science:

• Vascular Biology
• Cell Biology
• Transcription Factors

Background:

• Early B-cell factor-1 (EBF1) is a known transcription factor involved in cell lineage specification.
• Its role in vascular cells, particularly pericytes, has not been previously documented.
• EBF1 is critical for mesenchymal stem cell differentiation into adipocytes, osteoblasts, and muscle cells.

Purpose of the Study:

• To investigate the expression and function of EBF1 in vascular peri-endothelial cells.
• To determine if EBF1 plays a role in pericyte identification and differentiation.

Main Methods:

• Immunohistochemistry
• Quantitative reverse transcription polymerase chain reaction (RT-qPCR)
• Fluorescence-activated cell sorting (FACS)
• In vitro studies using human placenta-derived pericytes and human brain vascular pericytes (HBVP) with EBF1 silencing.

Main Results:

• EBF1 is highly expressed in peri-endothelial cells of both tumor and physiological vessels.
• EBF1-expressing cells exhibit pericyte markers (SMA, PDGFRβ, CD146, NG2).
• EBF1 silencing in HBVP cells reduced PDGFRβ and CD146 expression, and decreased levels of VEGF, angiopoietin-1, NG2, and TGF-β.

Conclusions:

• EBF1 is a key transcription factor expressed in pericytes.
• EBF1 plays a functional role in the cell fate commitment toward the pericyte phenotype.
• EBF1 influences pericyte differentiation and the expression of associated cytokines involved in angiogenesis.